Dr.Amal Louis done a lot of research in heart failure and telemonitoring for heart failure. Pioneered Enhanced External Counterpulsation therapy (EECP) in UK for patients with chest pain. Dr Amal Louis has been priniciple investigator and co-investigator for various multicentre international randomized control trials. He has presented and been a faculty at various European and American cardiac society meetings. Following is some of his publications from various peer reviewed international journals:
A Systematic review of Telecare for the Management of Heart Failure – European Journal of Heart Failure Non-Invasive Home Telemonitoring for Patients with Heart Failure at High Risk of Recurrent Admission and Death: (TEN-HMS) Study – JACC 2005 May 17 ; 45(10): 1654 – 64
The immediate and longterm outome of enhanced external counterpulsation (EECP) in treatment of chronic stable refractory angina- Journal of Internal medicine 2006; 259; 276-284.
Stent perforation treated by balloon tamponade -British Journal of Cardiology Feb 2006 Subintimal dissection to treat a chronically occluded coronary artery with PCI – British Journal of cardiology July 2005.
Coronary Artery Dissection secondary to Cocaine Abuse – British Journal of Cardiology, June 2011.
Pharmacoeconomics in heart failure: impact of drug and non-drug based treatment. European Heart Journal Supplements (2001) 3 (Supplement G), G25-G32. Polypharmacy (or Polytherapy) in the Treatment of Heart Failure. Heart Failure Monitor 2000; 1: 8-13. The Heart Failure Journal Club: a review of publications on Heart Failure in the European Heart Journal. Eur J Heart Failure 4(2002) 105-109.
CAPRICORN, COPERNICUS, MIRACL, STAF, RITZ-2, RECOVER, RENAISSANCE and Cachexia and Cholesterol in heart failure. Highlights of the Scientific sessions of the American College of Cardiology, 2001. Eur J Heart Failure 2001 Jun ; 3(3): 381-7 Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Eur J Heart Failure 4 (2002) 111- 116.